Bioretec Oy Yönetim

Yönetim kriter kontrolleri 0/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Alan Donze

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	less than a year
CEO sahipliği	n/a
Yönetim ortalama görev süresi	1.3yrs
Yönetim Kurulu ortalama görev süresi	1.7yrs

Son yönetim güncellemeleri

Recent updates

CEO

Alan Donze (59 yo)

less than a year

Görev süresi

Mr. Alan Donze is Chief Executive Officer of Bioretec Oy from May 20, 2024. Mr. Donze has held senior leadership positions for a number of other medical device and technology companies including Smith Neph...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Alan Donze	Chief Executive Officer	less than a year	Veri yok	Veri yok
Johanna Salko	Chief Financial Officer	3.8yrs	Veri yok	Veri yok
Esa Hallinen	Director of Operations	1.3yrs	Veri yok	Veri yok
Timo Lehtonen	Chief Technology Officer	less than a year	Veri yok	Veri yok
Rami Ojala	Sales & Marketing Director	2.8yrs	Veri yok	Veri yok

1.3yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim: BRETEC 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.3 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Tomi Numminen	Chairman of the Board	8.5yrs	Veri yok	Veri yok
Kustaa Poutiainen	Director	1.5yrs	Veri yok	Veri yok
Sarah Van Hellenberg Hubar-Fisher	Director	3.6yrs	Veri yok	Veri yok
Michael Piccirillo	Director	6.8yrs	Veri yok	Veri yok
Paivi Malinen	Director	2.6yrs	Veri yok	Veri yok
Klaus Dresing	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Fan Liu	Member of Scientific Advisory Board	1.7yrs	Veri yok	Veri yok
Theddy Slongo	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Jeffrey Wang	Member of Scientific Advisory Board	1.7yrs	Veri yok	Veri yok
Richard Assaker	Member of Scientific Advisory Board	1.7yrs	Veri yok	Veri yok
Stefan Rammelt	Member of Scientific Advisory Board	1.3yrs	Veri yok	Veri yok
Verena Schreiber	Member of Scientific Advisory Board	1.3yrs	Veri yok	Veri yok

1.7yrs

Ortalama Görev Süresi

53yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: BRETEC 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 1.7 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.

Bioretec Oy Yönetim

Yönetim kriter kontrolleri 0/4

Anahtar bilgiler

Son yönetim güncellemeleri

Bioretec Oy Shareholders' Nomination Board Appointed

Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors

Bioretec Ltd Announces CEO Changes

Bioretec Ltd Unveils Its Revitalized Scientific Advisory Board

Bioretec Oy Appoints Esa Hallinen as Director of Operations and Member of the Management Team

Bioretec Oy Approves Management Appointments

Recent updates

Bioretec Ltd. Updates Its Product Development Strategy by Accelerating the Product Development of RemeOs™? Spinal Interbody Cage

Bioretec Oy Shareholders' Nomination Board Appointed

Bioretec Ltd. Reports Successful Clinical Outcomes from U.S. Controlled Launch of RemeOs Trauma Screw

Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors

Bioretec Ltd. Receives a Patent by the U.S. Patent Office for its RemeOs Magnesium Alloy Composition

Bioretec Has Been Granted FDA Breakthrough Device Designation Status for its RemeOs Spinal Interbody Cage

New minor risk - Share price stability

Bioretec's European Market Authorization for RemeOs Trauma Screw Proceeded to Expert Panel Evaluation

Bioretec Oy to Report Q2, 2024 Results on Aug 15, 2024

Bioretec Ltd Announces CEO Changes

Bioretec Estimates the Approval of the European Market Authorization for the Biodegradable RemeOs™ Trauma Screw Will Move to the First Quarter of 2024

Bioretec Estimates the Approval of the European Market Authorization for the Biodegradable RemeOs™ Trauma Screw Will Move to the First Quarter of 2024

Bioretec Ltd Unveils Its Revitalized Scientific Advisory Board

Bioretec Oy Appoints Esa Hallinen as Director of Operations and Member of the Management Team

Bioretec Oy Approves Management Appointments

Bioretec Ltd Appoints Dr. Jeremy Dublon as Regulatory Advisor

Bioretec Ltd Submits Additional Information Requested by the FDA for US Registration of RemeOs Trauma Screws

Bioretec Oy to Report First Half, 2023 Results on Aug 11, 2023

No independent directors

Bioretec Ltd, Updates Estimate of U.S. registration of RemeOs™ Screws and Expects Approval in April 2023

Bioretec's Hybrid Composite Patent Has Been Approved in Europe

Bioretec Oy Announces ActivaPin Bioresorbable Implant Provides Good Alternative Treatment of Pediatric Elbow Injuries

Bioretec Ltd Announces Bioresorbable Activa IM-Nail™ Shows Convincing Results in Post-Market Clinical Follow Up Study for the Treatment of Children's Forearm Fractures

Bioretec Ltd Submits Market Authorization Request for Its Bioresorbable RemeOs™ Magnesium Screw in the U.S

No independent directors

Bioretec's ActivaPin(TM) Bioresorbable Implant Provides Excellent Clinical Outcome in the Treatment of Pediatric Wrist Fractures

Bioretec Oy Announces Appointment of Päivi Malinen as Member of the Board of Directors

Bioretec Oy has completed an IPO in the amount of €1.74 million.

No independent directors

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş